Voyager Therapeutics Inc (VYGR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

75 SIDNEY STREET CAMBRIDGE, MA 02139

Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager's wholly owned and partnered pipeline focuses on severe neurological diseases for which effective new therapies are needed, including Parkinson's disease, Huntington's disease, Friedreich's ataxia, and other severe neurological diseases.

Data as of 2021-09-19 13:01:17 -0400
Market Cap117.98 Million Shares Outstanding37.936 Million Avg 30-day Volume195.071 Thousand
P/E Ratio6.58517 Dividend Yield EPS0.476
Price/Sales0.8922 Debt to Equity1.89 EBITDA11.132 Million
Price to Book Value1.07 Forward PE-0.1 Enterprise Value-25.001 Million
Total Cash142.981 Million Current Debt24.688 Million Gross Profit132.238 Million
BETA1.23993 52-week High/Low12.65 / 2.82 Next Earnings Date2021-11-08 Price to Cash FLow (P/CF) -5.1735
Data provided by IEX Cloud
View SEC Filings from VYGR instead.

View recent insider trading info

Funds Holding VYGR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VYGR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PIERCE GLENN INTERIM CSO

  • Officer
  • Director
42,000 2021-06-07 2

LEVIN MARK J

  • Director
  • 10% Owner
15,000 2021-06-03 1

PAUL STEVEN M

  • Director
15,000 2021-06-03 1

GERAGHTY JAMES A

  • Director
15,000 2021-06-03 1

HIGGINS MICHAEL J INTERIM PRESIDENT & CEO

  • Officer
  • Director
115,000 2021-06-03 1

HYMAN STEVEN

  • Director
15,000 2021-06-03 1

VITALE NANCY

  • Director
15,000 2021-06-03 1

KHWAJA OMAR SEE REMARKS

  • Officer
120,509 2021-05-21 4

HESSLEIN ROBERT W. SENIOR VP & GENERAL COUNSEL

  • Officer
110,056 2021-04-05 4

DORVAL ALLISON CHIEF FINANCIAL OFFICER

  • Officer
109,894 2021-03-19 4

TURENNE ANDRE PRESIDENT & CEO

  • Officer
  • Director
322,375 2021-03-19 4

DIXON WENDY L

  • Director
0 2020-06-04 0

OTTMER MATTHEW P. CHIEF OPERATING OFFICER

  • Officer
26,276 2020-01-21 0

KARSEN PERRY A

  • Director
0 2019-06-13 0

NEUROCRINE BIOSCIENCES INC

  • 10% Owner
0 2019-03-12 0

SAH DINAH PH.D. CHIEF SCIENTIFIC OFFICER

  • Officer
163,688 2019-01-11 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

STARR KEVIN P

TEPPER ROBERT I

  • 10% Owner
6,464,577 2018-09-19 0

RAVINA BERNARD CHIEF MEDICAL OFFICER

  • Officer
0 2018-04-10 0

HENDERSON JANE SR. V.P. & CFO, CORP. DEV.

  • Officer
0 2018-03-22 0

GOATER JEFF CHIEF FINANCIAL OFFICER

  • Officer
0 2016-02-01 0

SANOFI

  • FORMER 10% OWNER
No longer subject to file 2015-11-16 0

HADLEY HARBOR MASTER INVESTORS (CAYMAN) L.P.

  • 10% Owner
No longer subject to file 2015-11-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 21:15:03 UTC -0.467 0.537 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 20:45:03 UTC -0.467 0.537 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 20:15:03 UTC -0.467 0.537 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 19:45:03 UTC -0.467 0.537 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 19:15:03 UTC -0.467 0.537 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 18:45:03 UTC -0.467 0.537 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 18:15:03 UTC -0.467 0.537 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 17:45:03 UTC -0.467 0.537 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 17:15:03 UTC -0.467 0.537 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 16:45:03 UTC -0.461 0.531 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 16:15:03 UTC -0.461 0.531 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 15:45:04 UTC -0.461 0.531 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 15:15:04 UTC -0.461 0.531 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 14:45:03 UTC -0.4477 0.5177 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 14:15:03 UTC -0.4477 0.5177 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 13:45:03 UTC -0.4477 0.5177 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 13:15:03 UTC -0.4477 0.5177 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-21 12:45:03 UTC -0.4477 0.5177 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-20 22:15:03 UTC -0.4477 0.5177 750000
VOYAGER THERAPEUTICS INC VYGR 2021-09-20 21:45:03 UTC -0.4477 0.5177 750000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund VYGR -4.0 shares, $-36.6 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund VYGR -10.0 shares, $-91.5 2020-03-31 N-PORT

Elevate your investments